Cargando…

Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g

BACKGROUND: Retinopathy of prematurity (ROP) is a significant morbidity in preterm babies. Multiple risk factors for severe ROP have been extensively studied, however, only a few studies have included maternal diabetes mellitus (MDM) in their assessment. ROP and diabetic retinopathy are both retinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Opara, Chibuzor Nonye, Akintorin, Mopelola, Byrd, Allison, Cirignani, Natascha, Akintorin, Similolu, Soyemi, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398545/
https://www.ncbi.nlm.nih.gov/pubmed/32745146
http://dx.doi.org/10.1371/journal.pone.0236639
_version_ 1783565980786491392
author Opara, Chibuzor Nonye
Akintorin, Mopelola
Byrd, Allison
Cirignani, Natascha
Akintorin, Similolu
Soyemi, Kenneth
author_facet Opara, Chibuzor Nonye
Akintorin, Mopelola
Byrd, Allison
Cirignani, Natascha
Akintorin, Similolu
Soyemi, Kenneth
author_sort Opara, Chibuzor Nonye
collection PubMed
description BACKGROUND: Retinopathy of prematurity (ROP) is a significant morbidity in preterm babies. Multiple risk factors for severe ROP have been extensively studied, however, only a few studies have included maternal diabetes mellitus (MDM) in their assessment. ROP and diabetic retinopathy are both retinal vascular diseases in which there is leakage and/or neovascularization from damaged retinal vessels. Diabetes may affect ROP development; however, there are conflicting results on the association between MDM and ROP. OBJECTIVE: To determine if MDM is an independent risk factor for clinically significant ROP (ROP > Stage II) in neonates weighing less than 1500g. DESIGN/METHOD: We conducted a retrospective cohort study of neonates weighing <1500g who were delivered or transferred into our institution from 2007 through 2017. Logistic regression was used to analyze the association between severe ROP and MDM. The risks for the different stages of ROP from MDM were compared using chi-square linear trend test. RESULTS: We extracted 883 paired maternal-neonatal data. The mean (standard deviation) gestational age and birthweight were 28.5 (2.9) weeks and 1052.7 (300.9) grams, respectively. Of the 883 mothers, 72 (8.2%) had DM. The incidence of ROP and severe ROP was 42.4% (374/883) and 6.5% (57/883) respectively. The odds ratio comparing MDM and severe ROP was 3.47 [95% CI: 1.51–7.96]; p<0.01). Compared to Stage I, the risk of MDM in infants with ROP increased from 1.49 in Stage II ROP to 2.59 in Stages III&IV. Severe ROP was associated with infant steroid use (OR: 5.92 [95% CI: 2.83–12.38]; p <0.01), sepsis (OR: 2.13 [95% CI: 1.09–4.14]; p = 0.03) chorioamnionitis (OR: 1.90 [95% CI: 1.03–3.50]; p = 0.04), and maternal steroid use (OR: 0.51 [95% CI: 0.32–0.79]; p<0.01). CONCLUSION: Maternal diabetes is associated with ROP and the strength of association increased with increasing severity of ROP.
format Online
Article
Text
id pubmed-7398545
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-73985452020-08-14 Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g Opara, Chibuzor Nonye Akintorin, Mopelola Byrd, Allison Cirignani, Natascha Akintorin, Similolu Soyemi, Kenneth PLoS One Research Article BACKGROUND: Retinopathy of prematurity (ROP) is a significant morbidity in preterm babies. Multiple risk factors for severe ROP have been extensively studied, however, only a few studies have included maternal diabetes mellitus (MDM) in their assessment. ROP and diabetic retinopathy are both retinal vascular diseases in which there is leakage and/or neovascularization from damaged retinal vessels. Diabetes may affect ROP development; however, there are conflicting results on the association between MDM and ROP. OBJECTIVE: To determine if MDM is an independent risk factor for clinically significant ROP (ROP > Stage II) in neonates weighing less than 1500g. DESIGN/METHOD: We conducted a retrospective cohort study of neonates weighing <1500g who were delivered or transferred into our institution from 2007 through 2017. Logistic regression was used to analyze the association between severe ROP and MDM. The risks for the different stages of ROP from MDM were compared using chi-square linear trend test. RESULTS: We extracted 883 paired maternal-neonatal data. The mean (standard deviation) gestational age and birthweight were 28.5 (2.9) weeks and 1052.7 (300.9) grams, respectively. Of the 883 mothers, 72 (8.2%) had DM. The incidence of ROP and severe ROP was 42.4% (374/883) and 6.5% (57/883) respectively. The odds ratio comparing MDM and severe ROP was 3.47 [95% CI: 1.51–7.96]; p<0.01). Compared to Stage I, the risk of MDM in infants with ROP increased from 1.49 in Stage II ROP to 2.59 in Stages III&IV. Severe ROP was associated with infant steroid use (OR: 5.92 [95% CI: 2.83–12.38]; p <0.01), sepsis (OR: 2.13 [95% CI: 1.09–4.14]; p = 0.03) chorioamnionitis (OR: 1.90 [95% CI: 1.03–3.50]; p = 0.04), and maternal steroid use (OR: 0.51 [95% CI: 0.32–0.79]; p<0.01). CONCLUSION: Maternal diabetes is associated with ROP and the strength of association increased with increasing severity of ROP. Public Library of Science 2020-08-03 /pmc/articles/PMC7398545/ /pubmed/32745146 http://dx.doi.org/10.1371/journal.pone.0236639 Text en © 2020 Opara et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Opara, Chibuzor Nonye
Akintorin, Mopelola
Byrd, Allison
Cirignani, Natascha
Akintorin, Similolu
Soyemi, Kenneth
Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g
title Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g
title_full Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g
title_fullStr Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g
title_full_unstemmed Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g
title_short Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g
title_sort maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398545/
https://www.ncbi.nlm.nih.gov/pubmed/32745146
http://dx.doi.org/10.1371/journal.pone.0236639
work_keys_str_mv AT oparachibuzornonye maternaldiabetesmellitusasanindependentriskfactorforclinicallysignificantretinopathyofprematurityseverityinneonateslessthan1500g
AT akintorinmopelola maternaldiabetesmellitusasanindependentriskfactorforclinicallysignificantretinopathyofprematurityseverityinneonateslessthan1500g
AT byrdallison maternaldiabetesmellitusasanindependentriskfactorforclinicallysignificantretinopathyofprematurityseverityinneonateslessthan1500g
AT cirignaninatascha maternaldiabetesmellitusasanindependentriskfactorforclinicallysignificantretinopathyofprematurityseverityinneonateslessthan1500g
AT akintorinsimilolu maternaldiabetesmellitusasanindependentriskfactorforclinicallysignificantretinopathyofprematurityseverityinneonateslessthan1500g
AT soyemikenneth maternaldiabetesmellitusasanindependentriskfactorforclinicallysignificantretinopathyofprematurityseverityinneonateslessthan1500g